1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > Asia-Pacific Clinical Chemistry Market Outlook to 2021

Asia-Pacific Clinical Chemistry Market Outlook to 2021

  • October 2015
  • -
  • Global Data
  • -
  • 140 pages

Asia-Pacific Clinical Chemistry Market Outlook to 2021

Summary

GlobalData’s new report, "Asia-Pacific Clinical Chemistry Market Outlook to 2021", provides key market data on the Asia-Pacific Clinical Chemistry market. The report provides value, in millions of US dollars within market segments - Clinical Chemistry Analyzers, Clinical Chemistry Rapid Tests & POC, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, Metabolite Chemistry Reagents, Therapeutic Drug Monitoring and Urine Analysis.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Clinical Chemistry market includes Clinical Chemistry Analyzers, Clinical Chemistry Rapid Tests & POC, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, Metabolite Chemistry Reagents, Therapeutic Drug Monitoring and Urine Analysis.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Clinical Chemistry market.
- Global corporate-level profiles of key companies operating within the Asia-Pacific Clinical Chemistry market.
- Key players covered include Abbott Laboratories, Siemens Healthcare, F. Hoffmann-La Roche Ltd., Danaher Corporation, Ortho-Clinical Diagnostics Inc., bioMerieux S.A. and Bio-Rad Laboratories, Inc.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

Asia-Pacific Clinical Chemistry Market Outlook to 2021
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 9
2.1 What Is This Report About? 9
2.2 Clinical Chemistry Market Segmentation 9
2.3 Definitions of Markets Covered in the Report 10
3 Clinical Chemistry Market, Asia-Pacific 13
3.1 Clinical Chemistry Market, Asia-Pacific, Revenue ($m), 2007-2021 13
3.2 Clinical Chemistry Market, Asia-Pacific, Category Comparison by Revenue ($m), 2007-2021 15
3.3 Clinical Chemistry Market, Asia-Pacific, Revenue ($m), 2007-2014 17
3.4 Clinical Chemistry Market, Asia-Pacific, Revenue ($m), 2014-2021 19
3.5 Clinical Chemistry Market, Asia-Pacific, Company Share by Revenue ($m), 2014 21
4 Clinical Chemistry Market, Australia 23
4.1 Clinical Chemistry Market, Australia, Revenue ($m), 2007-2014 23
4.2 Clinical Chemistry Market, Australia, Revenue ($m), 2014-2021 25
4.2.1 Clinical Chemistry Analyzers Market, Australia, Revenue ($m), by Segment, 2007-2014 27
4.2.2 Therapeutic Drug Monitoring Market, Australia, Revenue ($m), by Segment, 2007-2014 29
4.2.3 Urine Analysis Market, Australia, Revenue ($m), by Segment, 2007-2014 31
4.2.4 Clinical Chemistry Analyzers Market, Australia, Revenue ($m), by Segment, 2014-2021 33
4.2.5 Therapeutic Drug Monitoring Market, Australia, Revenue ($m), by Segment, 2014-2021 35
4.2.6 Urine Analysis Market, Australia, Revenue ($m), by Segment, 2014-2021 37
4.3 Clinical Chemistry Market, Australia, Distribution Share by Revenue ($m), 2013-2014 39
4.4 Clinical Chemistry Market, Australia, Company Share by Revenue ($m), 2014 40
5 Clinical Chemistry Market, China 42
5.1 Clinical Chemistry Market, China, Revenue ($m), 2007-2014 42
5.2 Clinical Chemistry Market, China, Revenue ($m), 2014-2021 44
5.2.1 Clinical Chemistry Analyzers Market, China, Revenue ($m), by Segment, 2007-2014 46
5.2.2 Therapeutic Drug Monitoring Market, China, Revenue ($m), by Segment, 2007-2014 48
5.2.3 Urine Analysis Market, China, Revenue ($m), by Segment, 2007-2014 50
5.2.4 Clinical Chemistry Analyzers Market, China, Revenue ($m), by Segment, 2014-2021 52
5.2.5 Therapeutic Drug Monitoring Market, China, Revenue ($m), by Segment, 2014-2021 54
5.2.6 Urine Analysis Market, China, Revenue ($m), by Segment, 2014-2021 56
5.3 Clinical Chemistry Market, China, Distribution Share by Revenue ($m), 2013-2014 58
5.4 Clinical Chemistry Market, China, Company Share by Revenue ($m), 2014 59
6 Clinical Chemistry Market, India 61
6.1 Clinical Chemistry Market, India, Revenue ($m), 2007-2014 61
6.2 Clinical Chemistry Market, India, Revenue ($m), 2014-2021 63
6.2.1 Clinical Chemistry Analyzers Market, India, Revenue ($m), by Segment, 2007-2014 65
6.2.2 Therapeutic Drug Monitoring Market, India, Revenue ($m), by Segment, 2007-2014 67
6.2.3 Urine Analysis Market, India, Revenue ($m), by Segment, 2007-2014 69
6.2.4 Clinical Chemistry Analyzers Market, India, Revenue ($m), by Segment, 2014-2021 71
6.2.5 Therapeutic Drug Monitoring Market, India, Revenue ($m), by Segment, 2014-2021 73
6.2.6 Urine Analysis Market, India, Revenue ($m), by Segment, 2014-2021 75
6.3 Clinical Chemistry Market, India, Distribution Share by Revenue ($m), 2013-2014 77
6.4 Clinical Chemistry Market, India, Company Share by Revenue ($m), 2014 78
7 Clinical Chemistry Market, Japan 80
7.1 Clinical Chemistry Market, Japan, Revenue ($m), 2007-2014 80
7.2 Clinical Chemistry Market, Japan, Revenue ($m), 2014-2021 82
7.2.1 Clinical Chemistry Analyzers Market, Japan, Revenue ($m), by Segment, 2007-2014 84
7.2.2 Therapeutic Drug Monitoring Market, Japan, Revenue ($m), by Segment, 2007-2014 86
7.2.3 Urine Analysis Market, Japan, Revenue ($m), by Segment, 2007-2014 88
7.2.4 Clinical Chemistry Analyzers Market, Japan, Revenue ($m), by Segment, 2014-2021 90
7.2.5 Therapeutic Drug Monitoring Market, Japan, Revenue ($m), by Segment, 2014-2021 92
7.2.6 Urine Analysis Market, Japan, Revenue ($m), by Segment, 2014-2021 94
7.3 Clinical Chemistry Market, Japan, Distribution Share by Revenue ($m), 2013-2014 96
7.4 Clinical Chemistry Market, Japan, Company Share by Revenue ($m), 2014 97
8 Clinical Chemistry Market, South Korea 99
8.1 Clinical Chemistry Market, South Korea, Revenue ($m), 2007-2014 99
8.2 Clinical Chemistry Market, South Korea, Revenue ($m), 2014-2021 101
8.2.1 Clinical Chemistry Analyzers Market, South Korea, Revenue ($m), by Segment, 2007-2014 103
8.2.2 Therapeutic Drug Monitoring Market, South Korea, Revenue ($m), by Segment, 2007-2014 105
8.2.3 Urine Analysis Market, South Korea, Revenue ($m), by Segment, 2007-2014 107
8.2.4 Clinical Chemistry Analyzers Market, South Korea, Revenue ($m), by Segment, 2014-2021 109
8.2.5 Therapeutic Drug Monitoring Market, South Korea, Revenue ($m), by Segment, 2014-2021 111
8.2.6 Urine Analysis Market, South Korea, Revenue ($m), by Segment, 2014-2021 113
8.3 Clinical Chemistry Market, South Korea, Distribution Share by Revenue ($m), 2013-2014 115
8.4 Clinical Chemistry Market, South Korea, Company Share by Revenue ($m), 2014 116
9 Overview of Key Companies in Asia-Pacific Clinical Chemistry Market 118
9.1 Siemens Healthcare 118
9.1.1 Company Overview 118
9.2 F. Hoffmann-La Roche Ltd. 118
9.2.1 Company Overview 118
9.3 Danaher Corporation 118
9.3.1 Company Overview 118
9.4 Bio-Rad Laboratories, Inc. 119
9.4.1 Company Overview 119
9.5 Abbott Laboratories 119
9.5.1 Company Overview 119
9.6 bioMerieux S.A. 119
9.6.1 Company Overview 119
9.7 Sysmex Corporation 120
9.7.1 Company Overview 120
9.8 Ortho-Clinical Diagnostics Inc. 120
9.8.1 Company Overview 120
9.9 Transasia Bio-Medicals Ltd. 120
9.9.1 Company Overview 120
9.10 Agappe Diagnostics Ltd. 121
9.10.1 Company Overview 121
9.11 Mindray Medical International Limited 121
9.11.1 Company Overview 121
10 Clinical Chemistry Market Pipeline Products 122
11 Recent Developments 125
11.1 Corporate Communications 125
11.1.1 Jun 10, 2015: Samsung Medical Center acquires Asia's first Leksell Gamma Knife Icon system 125
11.1.2 Mar 06, 2015: Otsuka Pharmaceutical Appoints Board Members, Statutory Auditors 125
11.1.3 Feb 12, 2015: Notice of Change of Representative Director of Otsuka Pharmaceutical 126
11.2 Financial Announcements 126
11.2.1 Jun 05, 2015: InVivo Therapeutics Announces Enrollment of Third Patient in Pilot Spinal Cord Injury Trial 126
11.2.2 Jun 04, 2015: Guided Therapeutics Awarded Multiple Tenders for LuViva Advanced Cervical Scan Systems from Governments in Bangladesh 127
11.2.3 Jun 04, 2015: Philips debuts Alice NightOne at-home sleep disorder diagnostic system 128
11.2.4 Jun 04, 2015: FDA Clears NovaBay Pharmaceuticals' New High-Tech Device, intelli-Case, for Safely Disinfecting Contact Lenses with Hydrogen Peroxide 128
11.2.5 Jun 04, 2015: Roche receives FDA clearance for the cobas Cdiff Test to detect Clostridium difficile 129
11.2.6 Oct 10, 2014: Edan Introduces Acclarix Compact Ultrasound System at ANESTHESIOLOGY2014 130
11.3 Legal And Regulatory 133
11.3.1 Nov 03, 2014: Agilent Technologies Granted Dismissal in Patent Infringement Suit Brought by Genetic Technologies 133
11.4 Other Significant Developments 133
11.4.1 Aug 18, 2015: Ortho Clinical Diagnostics Selects Model N for Global Deployment of Revvy Configure Price Quote for Medical Technologies 133
11.5 Strategy And Business Planning 134
11.5.1 Mar 31, 2015: Completion of Construction for New Research Building in Fuji Research Park 134
11.5.2 Jan 27, 2015: Otsuka Australia Pharmaceutical Opens in Australia 134
11.5.3 Nov 21, 2014: Nutrition and Sante Inaugurates New Factory Expanding Production Base of the French Leader in Functional and Dietetic Foods 134
11.5.4 Nov 14, 2014: Otsuka Group Establishes New Company in Order to Strengthen Presence in Vending Machine Market 135
11.5.5 Nov 06, 2014: Analytik Jena Establishes Subsidiary in India 135
11.5.6 Oct 30, 2014: Kyowa Hakko Kirin Announces Completion of Construction for Drug Product Manufacturing Facility in the Takasaki Plant 136
12 Appendix 137
12.1 Research Methodology 138
12.1.1 Coverage 138
12.1.2 Secondary Research 138
12.1.3 Primary Research 138
12.1.4 Company Share Analysis 139
12.1.5 Distribution Share Analysis 139
12.2 GlobalData Consulting 139
12.3 Contact Us 139
12.4 Disclaimer 140

1.1 List of Tables
Table 1: Clinical Chemistry Market, Cross Country Comparison, Asia-Pacific, Revenue ($m), USD Constant, 2007-2021 14
Table 2: Clinical Chemistry Market, Asia-Pacific, Category Comparison by Revenue ($m), USD Constant, 2007-2021 16
Table 3: Clinical Chemistry Market, Asia-Pacific, Revenue ($m), Historic, USD Constant, 2007-2014 18
Table 4: Clinical Chemistry Market, Asia-Pacific, Revenue ($m), Forecast, USD Constant, 2014-2021 20
Table 5: Clinical Chemistry Market, Asia-Pacific, Company Share by Revenue ($m), USD Constant, 2014 22
Table 6: Clinical Chemistry Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 24
Table 7: Clinical Chemistry Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 26
Table 8: Clinical Chemistry Analyzers Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 28
Table 9: Therapeutic Drug Monitoring Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 30
Table 10: Urine Analysis Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 32
Table 11: Clinical Chemistry Analyzers Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 34
Table 12: Therapeutic Drug Monitoring Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 36
Table 13: Urine Analysis Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 38
Table 14: Clinical Chemistry Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2013-2014 39
Table 15: Clinical Chemistry Market, Australia, Company Share by Revenue ($m), USD Constant, 2014 41
Table 16: Clinical Chemistry Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 43
Table 17: Clinical Chemistry Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 45
Table 18: Clinical Chemistry Analyzers Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 47
Table 19: Therapeutic Drug Monitoring Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 49
Table 20: Urine Analysis Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 51
Table 21: Clinical Chemistry Analyzers Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 53
Table 22: Therapeutic Drug Monitoring Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 55
Table 23: Urine Analysis Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 57
Table 24: Clinical Chemistry Market, China, Distribution Share by Revenue ($m), USD Constant, 2013-2014 58
Table 25: Clinical Chemistry Market, China, Company Share by Revenue ($m), USD Constant, 2014 60
Table 26: Clinical Chemistry Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 62
Table 27: Clinical Chemistry Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 64
Table 28: Clinical Chemistry Analyzers Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 66
Table 29: Therapeutic Drug Monitoring Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 68
Table 30: Urine Analysis Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 70
Table 31: Clinical Chemistry Analyzers Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 72
Table 32: Therapeutic Drug Monitoring Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 74
Table 33: Urine Analysis Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 76
Table 34: Clinical Chemistry Market, India, Distribution Share by Revenue ($m), USD Constant, 2013-2014 77
Table 35: Clinical Chemistry Market, India, Company Share by Revenue ($m), USD Constant, 2014 79
Table 36: Clinical Chemistry Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 81
Table 37: Clinical Chemistry Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 83
Table 38: Clinical Chemistry Analyzers Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 85
Table 39: Therapeutic Drug Monitoring Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 87
Table 40: Urine Analysis Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 89
Table 41: Clinical Chemistry Analyzers Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 91
Table 42: Therapeutic Drug Monitoring Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 93
Table 43: Urine Analysis Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 95
Table 44: Clinical Chemistry Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2013-2014 96
Table 45: Clinical Chemistry Market, Japan, Company Share by Revenue ($m), USD Constant, 2014 98
Table 46: Clinical Chemistry Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 100
Table 47: Clinical Chemistry Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 102
Table 48: Clinical Chemistry Analyzers Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 104
Table 49: Therapeutic Drug Monitoring Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 106
Table 50: Urine Analysis Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 108
Table 51: Clinical Chemistry Analyzers Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 110
Table 52: Therapeutic Drug Monitoring Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 112
Table 53: Urine Analysis Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 114
Table 54: Clinical Chemistry Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2013-2014 115
Table 55: Clinical Chemistry Market, South Korea, Company Share by Revenue ($m), USD Constant, 2014 117
Table 56: Clinical Chemistry Market Pipeline Products 122

1.2 List of Figures
Figure 1: Clinical Chemistry Market, Cross Country Comparison, Asia-Pacific, Revenue ($m), USD Constant, 2007-2021 13
Figure 2: Clinical Chemistry Market, Asia-Pacific, Category Comparison by Revenue ($m), USD Constant, 2007-2021 15
Figure 3: Clinical Chemistry Market, Asia-Pacific, Revenue ($m), Historic, USD Constant, 2007-2014 17
Figure 4: Clinical Chemistry Market, Asia-Pacific, Revenue ($m), Forecast, USD Constant, 2014-2021 19
Figure 5: Clinical Chemistry Market, Asia-Pacific, Company Share (%) 2014 21
Figure 6: Clinical Chemistry Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 23
Figure 7: Clinical Chemistry Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 25
Figure 8: Clinical Chemistry Analyzers Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 27
Figure 9: Therapeutic Drug Monitoring Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 29
Figure 10: Urine Analysis Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 31
Figure 11: Clinical Chemistry Analyzers Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 33
Figure 12: Therapeutic Drug Monitoring Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 35
Figure 13: Urine Analysis Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 37
Figure 14: Clinical Chemistry Market, Australia, Company Share (%) 2014 40
Figure 15: Clinical Chemistry Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 42
Figure 16: Clinical Chemistry Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 44
Figure 17: Clinical Chemistry Analyzers Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 46
Figure 18: Therapeutic Drug Monitoring Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 48
Figure 19: Urine Analysis Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 50
Figure 20: Clinical Chemistry Analyzers Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 52
Figure 21: Therapeutic Drug Monitoring Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 54
Figure 22: Urine Analysis Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 56
Figure 23: Clinical Chemistry Market, China, Company Share (%) 2014 59
Figure 24: Clinical Chemistry Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 61
Figure 25: Clinical Chemistry Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 63
Figure 26: Clinical Chemistry Analyzers Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 65
Figure 27: Therapeutic Drug Monitoring Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 67
Figure 28: Urine Analysis Market, India, Revenue ($m), USD Constant, Historic, 2007-2014 69
Figure 29: Clinical Chemistry Analyzers Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 71
Figure 30: Therapeutic Drug Monitoring Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 73
Figure 31: Urine Analysis Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021 75
Figure 32: Clinical Chemistry Market, India, Company Share (%) 2014 78
Figure 33: Clinical Chemistry Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 80
Figure 34: Clinical Chemistry Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 82
Figure 35: Clinical Chemistry Analyzers Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 84
Figure 36: Therapeutic Drug Monitoring Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 86
Figure 37: Urine Analysis Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 88
Figure 38: Clinical Chemistry Analyzers Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 90
Figure 39: Therapeutic Drug Monitoring Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 92
Figure 40: Urine Analysis Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 94
Figure 41: Clinical Chemistry Market, Japan, Company Share (%) 2014 97
Figure 42: Clinical Chemistry Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 99
Figure 43: Clinical Chemistry Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 101
Figure 44: Clinical Chemistry Analyzers Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 103
Figure 45: Therapeutic Drug Monitoring Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 105
Figure 46: Urine Analysis Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 107
Figure 47: Clinical Chemistry Analyzers Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 109
Figure 48: Therapeutic Drug Monitoring Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 111
Figure 49: Urine Analysis Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 113
Figure 50: Clinical Chemistry Market, South Korea, Company Share (%) 2014 116

Companies mentioned
Siemens Healthcare
F. Hoffmann-La Roche Ltd.
Danaher Corporation
Bio-Rad Laboratories, Inc.
Abbott Laboratories
bioMerieux S.A.
Sysmex Corporation
Ortho-Clinical Diagnostics Inc.
Transasia Bio-Medicals Ltd.
Agappe Diagnostics Ltd.
Mindray Medical International Limited

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Future Horizons and Growth Strategies in the World Clinical Chemistry and Immunodiagnostic Markets: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

Future Horizons and Growth Strategies in the World Clinical Chemistry and Immunodiagnostic Markets: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 23500
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $37,500.  DataPack (test volumes, sales forecasts, supplier shares) $23,500. VPGMarketResearch.com's new report is a seven-country strategic analysis of major business opportunities emerging ...

Immunodiagnostics 2020: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts for 100 Tests--Clinical Chemistry, Drugs of Abuse, Endocrine Function, Immunoproteins, Special Chemistry, Therapeutic Drug Monitoring (TDM), Tumor Markers

Immunodiagnostics 2020: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts for 100 Tests--Clinical Chemistry, Drugs of Abuse, Endocrine Function, Immunoproteins, Special Chemistry, Therapeutic Drug Monitoring (TDM), Tumor Markers

  • $ 23500
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report PDF $37,500, DataPack (500 tables) $23,500. The report is available by geographic region, country, section, market segment, test category, and individual assay. VPGMarketResearch.com new ...

2016 Competing in the Global Clinical Chemistry and Immunodiagnostic Markets

2016 Competing in the Global Clinical Chemistry and Immunodiagnostic Markets

  • $ 21800
  • Industry report
  • October 2016
  • by Venture Planning Group

The new seven-country market intelligence and technology assessment study from VPGMarketResearch.com was designed to help current suppliers and potential market entrants identify and evaluate emerging ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.